A citation-based method for searching scientific literature

Randall J Bateman, Chengjie Xiong, Tammie L S Benzinger, Anne M Fagan, Alison Goate, Nick C Fox, Daniel S Marcus, Nigel J Cairns, Xianyun Xie, Tyler M Blazey, David M Holtzman, Anna Santacruz, Virginia Buckles, Angela Oliver, Krista Moulder, Paul S Aisen, Bernardino Ghetti, William E Klunk, Eric McDade, Ralph N Martins, Colin L Masters, Richard Mayeux, John M Ringman, Martin N Rossor, Peter R Schofield, Reisa A Sperling, Stephen Salloway, John C Morris. N Engl J Med 2012
Times Cited: 2053







List of co-cited articles
769 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Clifford R Jack, David A Bennett, Kaj Blennow, Maria C Carrillo, Billy Dunn, Samantha Budd Haeberlein, David M Holtzman, William Jagust, Frank Jessen, Jason Karlawish,[...]. Alzheimers Dement 2018
36

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Guy M McKhann, David S Knopman, Howard Chertkow, Bradley T Hyman, Clifford R Jack, Claudia H Kawas, William E Klunk, Walter J Koroshetz, Jennifer J Manly, Richard Mayeux,[...]. Alzheimers Dement 2011
18

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
Victor L Villemagne, Samantha Burnham, Pierrick Bourgeat, Belinda Brown, Kathryn A Ellis, Olivier Salvado, Cassandra Szoeke, S Lance Macaulay, Ralph Martins, Paul Maruff,[...]. Lancet Neurol 2013
16

High performance plasma amyloid-β biomarkers for Alzheimer's disease.
Akinori Nakamura, Naoki Kaneko, Victor L Villemagne, Takashi Kato, James Doecke, Vincent Doré, Chris Fowler, Qiao-Xin Li, Ralph Martins, Christopher Rowe,[...]. Nature 2018
630
14


Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.
Clifford R Jack, David S Knopman, William J Jagust, Ronald C Petersen, Michael W Weiner, Paul S Aisen, Leslie M Shaw, Prashanthi Vemuri, Heather J Wiste, Stephen D Weigand,[...]. Lancet Neurol 2013
13

Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study.
Brian A Gordon, Tyler M Blazey, Yi Su, Amrita Hari-Raj, Aylin Dincer, Shaney Flores, Jon Christensen, Eric McDade, Guoqiao Wang, Chengjie Xiong,[...]. Lancet Neurol 2018
208
13

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.
Clifford R Jack, David S Knopman, William J Jagust, Leslie M Shaw, Paul S Aisen, Michael W Weiner, Ronald C Petersen, John Q Trojanowski. Lancet Neurol 2010
13

The amyloid hypothesis of Alzheimer's disease at 25 years.
Dennis J Selkoe, John Hardy. EMBO Mol Med 2016
12

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Reisa A Sperling, Paul S Aisen, Laurel A Beckett, David A Bennett, Suzanne Craft, Anne M Fagan, Takeshi Iwatsubo, Clifford R Jack, Jeffrey Kaye, Thomas J Montine,[...]. Alzheimers Dement 2011
11

Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.
Brian W Kunkle, Benjamin Grenier-Boley, Rebecca Sims, Joshua C Bis, Vincent Damotte, Adam C Naj, Anne Boland, Maria Vronskaya, Sven J van der Lee, Alexandre Amlie-Wolf,[...]. Nat Genet 2019
788
11

The antibody aducanumab reduces Aβ plaques in Alzheimer's disease.
Jeff Sevigny, Ping Chiao, Thierry Bussière, Paul H Weinreb, Leslie Williams, Marcel Maier, Robert Dunstan, Stephen Salloway, Tianle Chen, Yan Ling,[...]. Nature 2016
10



A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers.
Clifford R Jack, David A Bennett, Kaj Blennow, Maria C Carrillo, Howard H Feldman, Giovanni B Frisoni, Harald Hampel, William J Jagust, Keith A Johnson, David S Knopman,[...]. Neurology 2016
650
9

Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease.
Eric McDade, Guoqiao Wang, Brian A Gordon, Jason Hassenstab, Tammie L S Benzinger, Virginia Buckles, Anne M Fagan, David M Holtzman, Nigel J Cairns, Alison M Goate,[...]. Neurology 2018
121
9

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Marilyn S Albert, Steven T DeKosky, Dennis Dickson, Bruno Dubois, Howard H Feldman, Nick C Fox, Anthony Gamst, David M Holtzman, William J Jagust, Ronald C Petersen,[...]. Alzheimers Dement 2011
8

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
Willemijn J Jansen, Rik Ossenkoppele, Dirk L Knol, Betty M Tijms, Philip Scheltens, Frans R J Verhey, Pieter Jelle Visser, Pauline Aalten, Dag Aarsland, Daniel Alcolea,[...]. JAMA 2015
792
8

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
Bob Olsson, Ronald Lautner, Ulf Andreasson, Annika Öhrfelt, Erik Portelius, Maria Bjerke, Mikko Hölttä, Christoffer Rosén, Caroline Olsson, Gabrielle Strobel,[...]. Lancet Neurol 2016
885
8

Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.
Heiko Braak, Dietmar R Thal, Estifanos Ghebremedhin, Kelly Del Tredici. J Neuropathol Exp Neurol 2011
983
8

Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis.
Davis C Ryman, Natalia Acosta-Baena, Paul S Aisen, Thomas Bird, Adrian Danek, Nick C Fox, Alison Goate, Peter Frommelt, Bernardino Ghetti, Jessica B S Langbaum,[...]. Neurology 2014
247
8


A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease.
Nicolas R Barthélemy, Yan Li, Nelly Joseph-Mathurin, Brian A Gordon, Jason Hassenstab, Tammie L S Benzinger, Virginia Buckles, Anne M Fagan, Richard J Perrin, Alison M Goate,[...]. Nat Med 2020
147
8

Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals.
Reisa A Sperling, Michael C Donohue, Rema Raman, Chung-Kai Sun, Roy Yaari, Karen Holdridge, Eric Siemers, Keith A Johnson, Paul S Aisen. JAMA Neurol 2020
70
10


Donanemab in Early Alzheimer's Disease.
Mark A Mintun, Albert C Lo, Cynthia Duggan Evans, Alette M Wessels, Paul A Ardayfio, Scott W Andersen, Sergey Shcherbinin, JonDavid Sparks, John R Sims, Miroslaw Brys,[...]. N Engl J Med 2021
142
7

Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.
Brian A Gordon, Tyler M Blazey, Jon Christensen, Aylin Dincer, Shaney Flores, Sarah Keefe, Charles Chen, Yi Su, Eric M McDade, Guoqiao Wang,[...]. Brain 2019
71
9

Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.
Sebastian Palmqvist, Shorena Janelidze, Yakeel T Quiroz, Henrik Zetterberg, Francisco Lopera, Erik Stomrud, Yi Su, Yinghua Chen, Geidy E Serrano, Antoine Leuzy,[...]. JAMA 2020
221
7

Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease.
Anne M Fagan, Chengjie Xiong, Mateusz S Jasielec, Randall J Bateman, Alison M Goate, Tammie L S Benzinger, Bernardino Ghetti, Ralph N Martins, Colin L Masters, Richard Mayeux,[...]. Sci Transl Med 2014
231
7

Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia.
Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist, Ruben Smith, Thomas G Beach, Geidy E Serrano, Xiyun Chai, Nicholas K Proctor, Udo Eichenlaub, Henrik Zetterberg,[...]. Nat Med 2020
248
7

High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis.
Suzanne E Schindler, James G Bollinger, Vitaliy Ovod, Kwasi G Mawuenyega, Yan Li, Brian A Gordon, David M Holtzman, John C Morris, Tammie L S Benzinger, Chengjie Xiong,[...]. Neurology 2019
204
7

Plasma β-amyloid in Alzheimer's disease and vascular disease.
Shorena Janelidze, Erik Stomrud, Sebastian Palmqvist, Henrik Zetterberg, Danielle van Westen, Andreas Jeromin, Linan Song, David Hanlon, Cristina A Tan Hehir, David Baker,[...]. Sci Rep 2016
266
7

Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis.
Vitaliy Ovod, Kara N Ramsey, Kwasi G Mawuenyega, Jim G Bollinger, Terry Hicks, Theresa Schneider, Melissa Sullivan, Katrina Paumier, David M Holtzman, John C Morris,[...]. Alzheimers Dement 2017
240
7

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.
William E Klunk, Henry Engler, Agneta Nordberg, Yanming Wang, Gunnar Blomqvist, Daniel P Holt, Mats Bergström, Irina Savitcheva, Guo-feng Huang, Sergio Estrada,[...]. Ann Neurol 2004
6

Neuroinflammation in Alzheimer's disease.
Michael T Heneka, Monica J Carson, Joseph El Khoury, Gary E Landreth, Frederic Brosseron, Douglas L Feinstein, Andreas H Jacobs, Tony Wyss-Coray, Javier Vitorica, Richard M Ransohoff,[...]. Lancet Neurol 2015
6

Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study.
Eric M Reiman, Yakeel T Quiroz, Adam S Fleisher, Kewei Chen, Carlos Velez-Pardo, Marlene Jimenez-Del-Rio, Anne M Fagan, Aarti R Shah, Sergio Alvarez, Andrés Arbelaez,[...]. Lancet Neurol 2012
301
6

Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease.
Oliver Preische, Stephanie A Schultz, Anja Apel, Jens Kuhle, Stephan A Kaeser, Christian Barro, Susanne Gräber, Elke Kuder-Buletta, Christian LaFougere, Christoph Laske,[...]. Nat Med 2019
316
6

A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.
Chad J Swanson, Yong Zhang, Shobha Dhadda, Jinping Wang, June Kaplow, Robert Y K Lai, Lars Lannfelt, Heather Bradley, Martin Rabe, Akihiko Koyama,[...]. Alzheimers Res Ther 2021
62
9

Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease.
Shorena Janelidze, David Berron, Ruben Smith, Olof Strandberg, Nicholas K Proctor, Jeffrey L Dage, Erik Stomrud, Sebastian Palmqvist, Niklas Mattsson-Carlgren, Oskar Hansson. JAMA Neurol 2021
53
11

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.
Kaj Blennow, Harald Hampel, Michael Weiner, Henrik Zetterberg. Nat Rev Neurol 2010
6

An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest.
Rahul S Desikan, Florent Ségonne, Bruce Fischl, Brian T Quinn, Bradford C Dickerson, Deborah Blacker, Randy L Buckner, Anders M Dale, R Paul Maguire, Bradley T Hyman,[...]. Neuroimage 2006
6

Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity.
Sebastian Palmqvist, Michael Schöll, Olof Strandberg, Niklas Mattsson, Erik Stomrud, Henrik Zetterberg, Kaj Blennow, Susan Landau, William Jagust, Oskar Hansson. Nat Commun 2017
321
6

The A4 study: stopping AD before symptoms begin?
Reisa A Sperling, Dorene M Rentz, Keith A Johnson, Jason Karlawish, Michael Donohue, David P Salmon, Paul Aisen. Sci Transl Med 2014
441
5

Amyloid-β imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods.
Susan M Landau, Christopher Breault, Abhinay D Joshi, Michael Pontecorvo, Chester A Mathis, William J Jagust, Mark A Mintun. J Nucl Med 2013
263
5

Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid.
Susan M Landau, Ming Lu, Abhinay D Joshi, Michael Pontecorvo, Mark A Mintun, John Q Trojanowski, Leslie M Shaw, William J Jagust. Ann Neurol 2013
234
5


Inflammation and Alzheimer's disease.
H Akiyama, S Barger, S Barnum, B Bradt, J Bauer, G M Cole, N R Cooper, P Eikelenboom, M Emmerling, B L Fiebich,[...]. Neurobiol Aging 2000
5

Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.
Gill Livingston, Jonathan Huntley, Andrew Sommerlad, David Ames, Clive Ballard, Sube Banerjee, Carol Brayne, Alistair Burns, Jiska Cohen-Mansfield, Claudia Cooper,[...]. Lancet 2020
5

Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease.
Randall J Bateman, Paul S Aisen, Bart De Strooper, Nick C Fox, Cynthia A Lemere, John M Ringman, Stephen Salloway, Reisa A Sperling, Manfred Windisch, Chengjie Xiong. Alzheimers Res Ther 2011
300
5

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
E H Corder, A M Saunders, W J Strittmatter, D E Schmechel, P C Gaskell, G W Small, A D Roses, J L Haines, M A Pericak-Vance. Science 1993
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.